Crinetics Pharmaceuticals, Inc. (CRNX)
36.35
-0.22
(-0.60%)
USD |
NASDAQ |
Apr 02, 12:52
Crinetics Pharmaceuticals Research and Development Expense (TTM) : 328.17M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Plus Therapeutics, Inc. | 8.379M |
| Nektar Therapeutics | 117.30M |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| Axsome Therapeutics, Inc. | 182.48M |
| Gossamer Bio, Inc. | 174.07M |